Covista (CVSA) Fundamental Analysis: Revenue, Earnings & Valuation

5.01 / 10

Netural

Fundamental health is fair (5/10). Strengths include a low long‑term debt‑to‑working‑capital ratio and a healthy equity multiplier. Weaknesses arise from modest net cash‑flow growth and profit margins. Overall score 5.01 reflects mixed factor contributions.

Analysis Checks(5/10)

Net cash flow from operating activities per share (YoY growth rate %)

Value19.74

Score1/3

Weight-0.74%

1M Return-0.11%

Equity multiplier

Value1.92

Score2/3

Weight1.16%

1M Return0.16%

Current liabilities / Total liabilities (%)

Value38.52

Score2/3

Weight22.39%

1M Return2.91%

Profit-MV

Value0.49

Score1/3

Weight2.65%

1M Return0.40%

Non-current liabilities / Total liabilities (%)

Value61.48

Score2/3

Weight37.19%

1M Return4.57%

Total profit / EBIT (%)

Value85.09

Score1/3

Weight7.46%

1M Return1.08%

Net cash flow from operating activities / Total liabilities (%)

Value0.26

Score2/3

Weight36.50%

1M Return4.51%

Long-term debt to working capital ratio (%)

Value6.45

Score2/3

Weight15.42%

1M Return2.37%

Asset-MV

Value-0.55

Score0/3

Weight-30.21%

1M Return-5.45%

Net profit / Total profit (%)

Value79.42

Score1/3

Weight8.18%

1M Return1.45%

Is CVSA undervalued or overvalued?

CVSA scores 5.01/10 on fundamentals and holds a Fair valuation at present. Backed by its 9.83% ROE, 13.41% net margin, 14.51 P/E ratio, 2.67 P/B ratio, and 27.55% earnings growth, these metrics solidify its Netural investment rating.